ImmunityBio Inc. Common Stock vs SanDisk — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while SanDisk trades at $1,645.19 (market cap $244.60B). The key difference: SanDisk is far larger — about 23.7× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is more actively traded (11,745,198 versus 9,095,556). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and SanDisk for 8 Days on average.
| IBRX | SNDK | |
|---|---|---|
Market Cap | $10.33B | $244.60B |
Volume | 11,745,198 | 9,095,556 |
Sector | Health | Technology |
52-Week High | $11.55 | $2.34K |
52-Week Low | $1.98 | $116.91 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $10.79B | $240.02B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Sandisk is a semiconductor memory company specializing in NAND flash technology. Its storage products support consumer devices, enterprise systems, and cloud and AI infrastructure.
Read more on SNDK →